share_log

HC Wainwright & Co. Reiterates Buy on Vera Therapeutics, Maintains $25 Price Target

Benzinga ·  Dec 27, 2023 11:21

HC Wainwright & Co. analyst Ed Arce reiterates Vera Therapeutics (NASDAQ:VERA) with a Buy and maintains $25 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment